For the full year, the company posted revenue of $706.9 million, down 14.1% from the $822.9 million recorded in FY2022.
Raffles Medical Group has reported patmi of $90.2 million in FY2023 ended December, 37.1% lower y-o-y on the discontinuance of Covid-19-related activities.
Earnings per share stood at 4.85 cents, compared to the 7.71 cents recorded in FY2022.
